BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18171345)

  • 1. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
    Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
    J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
    Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
    Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
    Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A candidate tumor suppressor gene mutated in primary hepatocellular carcinoma: kruppel-like factor 6].
    Wang SP; Chen XP; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1258-61. PubMed ID: 15598377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
    Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
    Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
    Liu LX; Jiang HC; Liu ZH; Zhu AL; Zhang WH; Wu LF; Zhou J; Wang XQ; Wu M
    Oncol Rep; 2003; 10(6):1771-5. PubMed ID: 14534694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma.
    Zhenzhen Z; De'an T; Limin X; Wei Y; Min L
    Hepatogastroenterology; 2012; 59(114):473-6. PubMed ID: 21940380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
    Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
    Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P
    Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
    Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.